Decannulation protocol in pediatric patients: case series study / Protocolo de decanulação pediátrica: um estudo de série de casos

ABSTRACT Objective: The aim of this study was to describe the phases of a decannulation protocol and the results from its application in hospitalized children. Methods: This is a retrospective, observational study. Data were collected from medical records of decannulated patients followed up in a pediatric hospital in Belo Horizonte, Minas Gerais between 2011 and 2021. Results: Among the children followed up in the service (n=526), 23% (n=120) were successfully decannulated. Children aged between 2 months and 16 years, with a mean age of 4 years, 69% of whom were male, were evaluated. About 75% of the patients have tracheostomy due to upper airway obstruction and 60% of these due to acquired subglottic stenosis. At the beginning of the decannulation protocol, 5.5% of the patients had moderate oropharyngeal dysphagia, while 80.4% had normal swallowing. Correction in the upper airway pre-decannulation was performed in 39.5% of the patients, dilation in 63.8%, and endoscopic correction was performed in 55.3%. After performing the decannulation, none of the patients had complications. Conclusions: The described decannulation protocol is safe, since no complications such as death and need for recannulation happened.

RESUMO Objetivo: Descrever as etapas de um protocolo de decanulação e os resultados da aplicação desse protocolo em crianças hospitalizadas. Métodos: Trata-se de um estudo observacional retrospectivo. Os dados foram coletados de prontuários de pacientes decanulados acompanhados em um hospital pediátrico de Belo Horizonte, Minas Gerais, entre 2011 e 2021. Resultados: Foram analisadas 120 crianças com idade entre dois meses e 16 anos, com média de idade de quatro anos, 69% das quais eram do sexo masculino. Cerca de 75% dos pacientes apresentam traqueostomia por obstrução de vias aéreas superiores e 60% destes por estenose subglótica adquirida. No início do protocolo de decanulação, 5,5% dos pacientes apresentavam disfagia orofaríngea moderada, enquanto 80,4% apresentavam deglutição normal. A correção da pré-decanulação das vias aéreas superiores foi realizada em 39,5% dos pacientes, a dilatação em 63,8% e a correção endoscópica em 55,3%. Após a realização da decanulação, nenhum paciente apresentou complicações. Conclusões: O protocolo de decanulação descrito é seguro, pois a taxa de complicações como óbito e a necessidade de recanulação foi ausente.

Hueso nasal como marcador de aneuploidías y resultado perinatal / Nasal bone as a marker of aneuploidies and perinatal outcome

Objetivo: Describir el resultado perinatal de los embarazos en función de la evaluación del hueso nasal como marcador de aneuploidía. Métodos: De 1006 embarazadas, 607 cumplieron con los criterios de inclusión para este estudio prospectivo, descriptivo, correlacional no causal donde se correlacionó la ausencia/presencia de hueso nasal con la presencia de síndrome de Down a través de cariotipo fetal prenatal y/o posnatal, así como examen clínico neonatal. Los datos fueron analizados mediantes frecuencias absolutas, porcentajes, capacidad diagnóstica del hueso nasal (índice de Youden), sensibilidad, especificidad, valor predictivo positivo, valor predictivo negativo y cocientes de probabilidad, positivo y negativo. Resultados: La prevalencia de síndrome de Down fue de 1,48 %, la ausencia del hueso nasal como marcador aislado, obtuvo un índice de Youden de 0,55 (0,23 - 0,88), sensibilidad de 55,56 %, especificidad de 99,50 %, valor predictivo positivo de 62,5 %, valor predictivo negativo de 99,33 %, cocientes de probabilidad positivo (hueso nasal ausente) 111 (IC 95 % 31 - 394) y cocientes de probabilidad negativo (hueso nasal presente) de 0,45 (IC 95 % 0,22 -0,93). Conclusión: La ausencia de hueso nasal en primer trimestre aumenta el riesgo de síndrome de Down en 111 veces y la presencia del mismo lo disminuye, sin valor como prueba diagnóstica sino de pesquisa debe considerarse como un marcador secundario(AU)

Objective: To know the perinatal outcome based on nasal bone evaluation as an aneuploidy marker. Methods: From 1006 pregnant women, 607 met the inclusion criteria for this prospective, descriptive, correlational not causal research correlating nasal bone absence / presence with Down syndrome through prenatal / postnatal fetal karyotype and neonatal clinical examination. Absolute frequencies and percentages, nasal bone performance as a diagnostic test (Youden índex), sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios positive and negative, were calculated. Results: 1.48 % was the Down syndrome prevalence on the sample. The nasal bone absence as an isolated marker obtained an 0,55 Youden index (0.23 to 0.88 ), sensitivity 55,56%, specificity 99,50%, positive predictive value 62,5%, negative predictive value 99,33%, likelihood ratios positive (absent nasal bone) 111, (95% CI 31-394) and likelihood ratios negative (nasal bone present ) 0,45 (95% CI 0 22 -0.93 ). Conclusion: The nasal bone absence in first trimester increases Down syndrome risk 111 times and nasal bone presence decreases it with poor performance as a diagnostic test, so it should be considered a screening test and a secondary marker. Recommendations correlate these results with other markers to improve detection rates and quantify nasal bone measurements in order to make nasal bone nomograms in first trimester pregnancies(AU)

El impacto silencioso de la rinitis sobre la vía aérea inferior / The silent correlate of rhinitis on lower airway

Resumen El aparato respiratorio, desde la nariz al pulmón, se comporta como una unidad anatómica y fisiopatológica bajo un modelo holístico. Se han observado alteraciones pulmonares sin traducción clínica en pacientes con rinitis sin asma, que se manifiestan como hiperreac tividad bronquial, reducción de la función pulmonar e inflamación bronquial. Estas serían consecuencia de un fenómeno inflamatorio sistémico con impacto simultá neo en nariz y pulmón, que por razones desconocidas no tiene una expresión clínica completa, pero que podrían significar un mayor riesgo de desarrollo de asma. En esta revisión abordamos la frecuencia y caracte rísticas de las anormalidades pulmonares existentes en niños y adolescentes con rinitis crónica derivadas de nuestras investigaciones previas y, más recientemente, del proyecto "Enfermedad Alérgica Respiratoria: El Con cepto de Unidad de la Vía Aérea", línea de investigación acreditada por la Universidad Católica de Córdoba y un análisis comparativo con las evidencias aportadas por otros autores en la literatura médica.

Abstract The respiratory tract, from the nose to the lung, behaves as an anatomical and pathophysiological unit under a holistic model. Lower airway abnormalities, such as bronchial hyperresponsiveness, reduced lung function and inflammation of the bronchial mucosa without clinical expression, have been observed in pa tients with rhinitis without asthma. These would be the consequence of a common systemic inflammatory phenomenon with simultaneous impact on the nose and lung. For unknown reasons, these patients do not exhibit a full clinical expression, which could mean an increased risk of developing asthma. In this review we address the frequency and charac teristics of existing pulmonary abnormalities in children and adolescents with chronic rhinitis that derive from our previous research and, more recently, within the project "Allergic Respiratory Disease: The United Airway Con cept" supported by the Universidad Católica de Córdoba, and a comparative analysis with the evidence provided by other authors in the medical literature.

Pediatric asthma and eosinophilia: insights from nasal and blood smear analyses

Background: Allergic respiratory maladies, particularly pediatric asthma, pose substantial challenges in public health. This cross-sectional investigation endeavours to unravel the eosinophilic landscape within nasal cytological specimens and peripheral blood samples of pediatric asthma cohorts, with a keen focus on discerning the correlation between nasal and systemic eosinophilia.Methods: Sixty-six pediatric asthma subjects, aged 6 to 18, under the care of Cheluvamba hospital in Mysuru, were meticulously recruited over an extensive 18-month period.Results: Analysis unveiled a conspicuous preponderance of male participants, with a mean age range spanning 9 to 13 years. Intriguingly, the presence of allergic rhinitis (AR) exhibited no discernible statistically significant nexus with either asthma severity or eosinophilic markers. Noteworthy findings include peripheral eosinophilia detected in 56% of subjects, juxtaposed against nasal eosinophilia observed in 20%; however, no statistically meaningful correlation emerged between nasal and peripheral eosinophilia.Conclusions: The inquiry culminated in a robust affirmation that mean nasal eosinophil count and blood absolute eosinophil count (AEC) exhibit a salient association with asthma severity and control in pediatric cohorts, irrespective of AR presence. Particularly, a discernible augmentation in mean AEC and nasal eosinophil count was discerned concomitant with exacerbating asthma severity and in cases of partial/ uncontrolled asthma.

The utility value of ROX index and modified ROX index in determining the efficiency of HFNC in children admitted with respiratory distress

Background: The ROX index is defined as the ratio of SpO2/FiO2 to respiratory rate. The modified ROX index or ROX-HR index is defined as the ratio of ROX index/heart rate�0. The aim of the study was to determine the utility of the ROX index and the modified ROX index as predictors of initiation and efficiency of HFNC in children admitted with respiratory distress.Methods: This prospective observational study included 133 children with respiratory distress, who received HFNC. The ROX index, and modified ROX index were measured, and outcomes were recorded.Results: Total number of study subjects were 133. Statistically significant increase was seen in ROX index and modified ROX index at follow up (p value<0.05). Interpretation of the area under the ROC curve showed that the performance of ROX index and modified ROX index at �hour was outstanding. ROX Index and modified ROX Index at a Cut-off of ?4.7959 and ?2.5579 respectively at initiation i. e.; at �hour predicted HFNC requirement. In prediction of HFNC requirement ROX index at �hour had a sensitivity, specificity, positive predictive value, and negative predictive value of 88.24%, 87.84%, 93%, and 80.2% respectively, and modified ROX index had 78.68%, 93.24%, 95.5%, and 70.4% respectively. Low ROX and modified ROX indices at �hour predicted prolonged ICU and hospital stays, as well as extended HFNC duration.Conclusions: Both ROX index, and modified ROX index were good predictors of HFNC requirement.

Epidemiology, surgical intervention and management of nasal trauma in the acute phase- clinical study in a tertiary centre

Background: The anatomy and location of nose makes it prone to blunt trauma. Delayed treatment leads to secondary nasal deformities and chronic nasal obstruction with difficult day-to-day activities. Methods: Institution-based prospective study done on 140 patients with recent trauma of nose coming to department of ENT, Gauhati medical college and hospital from August 2022-July 2023 to study different types of nasal trauma, clinical presentation, initial conservative and surgical management. Ethical approval taken from institutional ethics committee. Results: Male: female ratio 1.8:1 with 34.2% in 21-30 age-group followed-by 11-20. Most-common mechanism being road-traffic-accidents (35.7%) followed-by self-fall (25.7%), presentation being nasal bleed (97.1%) controlled with anterior nasal packing (70%), followed by swelling of nose (95.7%). Lacerations (60%) of nasal alae or dorsum repaired, septal-hematoma (5%) incised drained and splinted. CSF-rhinorrhoea (11.5%) managed conservatively. The 74.2% with nasal-bone fracture, 4.8% presenting <6 hours emergency reduction done, 11.5% closed reduction, 6.7% septo-rhinoplasty with tragal, costal cartilage grafts under general-anaesthesia. Conclusions: Injury to nose is common in male adolescents and adults due to RTAs. Prompt intervention necessary to prevent complications. Epidemiological facts advocate public health measures including strict traffic-rules, improving sports practices, interpersonal relationships, prevention of alcohol-intake while driving.

Estrategias de destete y desmonte de cánula nasal de alto flujo en adultos / Adult High-Flow Nasal Cannula Weaning and Disassembly Strategies

Introducción: La cánula nasal de alto flujo es un sistema que utiliza una mezcla de aire-oxígeno humidificado y calentado con un caudal de hasta 70 litros por minuto. Es utilizada mayoritariamente en la insuficiencia respiratoria aguda de origen hipoxémico, donde ha demostrado brindar mayor comodidad y poder resolutivo de la hipoxemia, en comparación con la oxigenoterapia convencional. Aunque se conocen sus indicaciones y estrategia de seguimiento, en la práctica clínica no es claro su proceso de destete/desmonte. Objetivo: Identificar en la bibliografía la literatura existente acerca de estrategias de destete/desmonte de la cánula nasal de alto flujo en adultos. Métodos: Se realizó una revisión bibliográfica en las bases de datos del portal regional de la BVS, PubMed, Web Of Science, Scopus y Google scholar, sin límite de tiempo y es- tructurando una ecuación PIO con palabras clave y operadores booleanos. Se asumieron artículos publicados en inglés y español, texto completo. Resultados: En la bibliografía, aún se reporta discrepancia en el proceso de destete y desmonte de la cánula nasal de alto flujo, pero en la mayoría de los estudios encontrados en esta revisión se propone disminuir la FiO2 primero de forma gradual (5-10%) hasta valores de 30-50% y, posteriormente, el flujo. Para desmontarla, se podría considerar tener una FiO2 entre 30-50%, flujo entre 20-30 litros por minuto, SaO2 >92%, con adecuada mecánica respiratoria y estado de conciencia. Conclusión: Aún no existe unanimidad en el proceso de destete/desmonte en la cánula nasal de alto flujo en el paciente adulto.

Introduction: The high-flow nasal cannula is a system that uses a humidified and heated air-oxygen mixture with a flow rate of up to 70 liters per minute. It is mostly used in acute respiratory failure of hypoxemic origin, where it has been shown to provide greater comfort and resolving power of hypoxemia, compared to conventional oxygen therapy. Although its indications and follow-up strategy are known, in clinical practice the weaning/weaning process is not clear. Objective: To identify in the bibliography the existing literature on weaning/ weaning strategies of high-flow nasal cannula in adults. Methods: A bibliographic review was carried out in the databases of the regional portal of the BVS, PubMed, Web Of Science, Scopus and Google scholar, without time limit and structuring a PIO equation with keywords and boléan connectors. Articles published in English and Spanish, full text, were assumed. Results: The literature still reports discrepancy in the process of weaning and disassembling the high-flow nasal cannula, but most of the studies found in this review propose to decrease the FiO2 first gradually (5-10%) to values of 30-50% and then the flow. To dismantle it, one could consider having a FiO2 between 30-50%, flow between 20-30 liters per minute, SaO2 >92%, with adequate respiratory mechanics and state of consciousness. Conclusion: There is still no unanimity on the weaning/weaning process in the high- flow nasal cannula in the adult patient.

¡¡¡Ni abierta, ni cerrada!!! Rinoplastia con lo mejor de las dos técnicas. Trick tip rhinoplasty (transcolumellar and inter cartilaginous keystoning with tip preservation) / Trick tip rhinoplasty (transcolumellar and inter cartilaginous keystoning with tip preservation)

El propósito es presentar una técnica de rinoplastia sin precedentes: la TRICK-TIP (transcolumellar and inter cartilaginous keystoning with tip preservation) usada por 14 años Métodos. La cirugía es indicada en casos estéticos primarios y secundarios y también en reconstructivos como nariz hendida y secuelas de trauma. Una incisión nasal intercartilaginosa se continúa con una vertical en el septum membranoso y se "abre" con una incisión baja en escalera en la parte inferior de la columela, una combinación de elementos de las técnicas abierta y cerrada. La punta nasal se eleva como un colgajo que incluye los alares y la piel vestibular debajo de ellos. El abordaje es muy amplio para realizar todas las maniobras quirúrgicas para septum y dorso, mientras que la punta nasal se preserva anatómicamente y se modifi ca desde abajo por resección cefálica retrógrada de alares, aplicación de poste intercrural fi jado primero arriba y puntos para cierre de espacios muertos en el supra tip, el cierre de las incisiones es sencillo y completo, dos tercios de los casos se realiza resección de alas sin diferimiento. Resultados. Los resultados evaluados por 120 pacientes usando Face Q™, y por 102 evaluadores externos son muy satisfactorios, las complicaciones son bajas y las revisiones infrecuentes. No se presentaron deformidades de triángulos blandos ni de los rebordes de las narinas. De manera subjetiva el autor considera más rápida, barata y fácil esta cirugía mientras que da resultados satisfactorios. Discusión. La TRICK-TIP, una técnica original, convierte la rinoplastia cerrada en una con amplia visibilidad mientras preserva la anatomía de la punta. Su exposición extensa y rapidez permite realizar cambios estructurales complejos en el septum, dorso y vertientes nasales, mientras que maniobras indirectas permiten preservar las uniones interdomales, y proyectar la punta reduciendo espacios muertos. Conclusión. La técnica TRICK-TIP se ha convertido en la preferida del autor debido a su versatilidad y buenos resultados. Ofrece una combinación única de ventajas de los enfoques abiertos y cerrados, con énfasis en la preservación de la punta y la simplifi cación del procedimiento.

The aim is to present an unprecedented rhinoplasty technique, TRICK-TIP (Transcolumellar and Inter Cartilaginous Keystoning with Tip preservation), which has been used for 14 years. Methods:The Surgery is indicated for primary and secondary aesthetic cases, as well as reconstructive such as cleft nose and post-traumatic sequelae. An intercartilaginous endonasal incision is continued with a vertical incision in the membranous septum. It is "opened" with a stair-step incision in the lower part of the columella, combining elements of both open and closed rhinoplasties. The nasal tip is elevated as a composed fl ap that includes the alar cartilages and the vestibular skin beneath them. The approach is extensive to perform all surgical maneuvers for the septum and dorsum while anatomically preserving and modifying the nasal tip from below by retrograde cephalic resection of the alar cartilages, application of an intercrural strut fi xed fi rst superiorly, and closure points for dead spaces in the supratip. The closure of incisions is simple and complete, with two-thirds of cases undergoing alar resection without deferral. Results: The results evaluated by 120 patients using Face Q™ and by 102 external evaluators are highly satisfactory, with low complications and infrequent revisions. Soft triangle deformities or nasal rim deformities were not observed. Subjectively, the author considers this surgery to be faster, cheaper, and easier, yielding satisfactory results. Discussion: The TRICK-TIP, an original technique, transforms closed rhinoplasty into one with extensive visibility while preserving the anatomy of the nasal tip. Its extensive exposure and reduced surgical time allow for complex structural changes in the septum, dorsum, and nasal sidewalls, while indirect maneuvers preserve interdomal junctions and project the tip, reducing dead spaces. Conclusion: The TRICK-TIP technique has become the author's preferred method due to its versatility and good outcomes. It off ers a unique combination of advantages from both open and closed approaches, emphasizing tip preservation and procedural simplifi cation.

Guia prático para o uso de imunobiológicos em doenças alérgicas - ASBAI / Practical guide for the use of immunobiologic agents in allergic diseases - ASBAI

Os anticorpos monoclonais são uma nova classe de medicamentos que representa um marco na evolução da terapia de doenças alérgicas graves. Além de possibilitar uma terapia imunológica alvo específico, proporciona maior controle de sintomas, redução de exacerbações, melhoria da qualidade de vida e da segurança. A eficácia e a segurança dos anticorpos monoclonais no tratamento de doenças alérgicas estão bem documentadas nos estudos clínicos pivotais, de extensão e de vida real. No Brasil, estão licenciados atualmente pela Agência Nacional de Vigilância Sanitária (ANVISA) imunobiológicos para asma, dermatite atópica (DA), esofagite eosinofílica (EoE), granulomatose eosinofílica com poliangeíte (GEPA), rinossinusite crônica com pólipo nasal (RSCcPN), síndromes hipereosinofílicas (SHE) e urticária crônica espontânea (UCE). Com a incorporação do uso dessas novas terapias no dia a dia do médico alergologista e imunologista, naturalmente emergem aspectos práticos que exigem orientações práticas perante as evidências científicas mais atuais, a fim de se manter a boa prática médica, com uso criterioso e consciente pelo especialista capacitado. Assim, nesse guia prático, abordaremos os imunobiológicos aprovados até o momento para doenças alérgicas graves, com objetivo de auxiliar o especialista em Alergia e Imunologia na prescrição e manejo dessas medicações, incluindo indicações, contraindicações, monitoramento da eficácia e segurança, notificação de eventos adversos, bem como aspectos associados aos cuidados com vacinas, populações especiais, acesso, transporte, armazenamento e aplicação domiciliar.

Monoclonal antibodies are a new class of drugs that represent a milestone in the evolution of therapy for severe allergic diseases. In addition to allowing targeted immunologic therapy, they can improve symptom control, reduce exacerbations, and increase quality of life and safety. The efficacy and safety of monoclonal antibodies in the treatment of allergic diseases are well documented in pivotal, extension, and real-life clinical studies. In Brazil, immunobiologic agents are currently licensed by the National Health Surveillance Agency (ANVISA) for use in asthma, atopic dermatitis (AD), eosinophilic esophagitis (EoE), eosinophilic granulomatosis with polyangiitis (EGPA), chronic rhinosinusitis with nasal polyps (CRSwNP), hypereosinophilic syndrome (HES), and chronic spontaneous urticaria (CSU). With the incorporation of these new therapies into the daily practice of the allergist and immunologist, practical aspects will naturally emerge and require practical guidelines in light of the most current scientific evidence in order to maintain good medical practice, with judicious and conscious use by a qualified specialist. Therefore, in this practical guide, we will address the immunobiologic agents currently approved for severe allergic diseases, aiming to assist allergy and immunology specialists in the prescription and practical management of these medications, including indications, contraindications, efficacy and safety monitoring, adverse event reporting, as well as health care factors associated with vaccination, special populations, access, transport, storage, and home use.

Comparative Anatomy of the Vomeronasal Organ (VNO) in Sheep (Ovis aries) and Dogs (Canis familiaris) with Simple Reference to its Histological Structure and Vasculature Supply

SUMMARY: The vomeronasal organ (VNO) is located in the anteroinferior part of the nose and the accessory olfactory organ in mammals which is responsible of sense of smell. This study aims to compare the macro and microanatomical structure of the VNO between sheep and dogs. In the current study, we used ten adult slaughtered sheep and ten adult synchronized dogs with different sexes ages 1-2 years. The head of both animals were preserved in 10 % formalin for one week. This study shows in both animals, the VNO occupies the same position in the cavity of the vomer bone and the same relationship in the cranial part of the nasal cavity. Furthermore, the VNO is divided into three parts based on shape that are the rostral, central, and caudal part. The results show the VNO in sheep has a (U) shape and is opened dorsolaterally. It has a small and narrow cavity. It is long 6 cm long, and it has different diameters on its course. In comparison, the vomeronasal organ in dogs is very developed and has a (J) shape. It has a large and long cavity and ends at the fourth molar. Its length is about 10 cm, and it has one diameter on its course. The VNO receives the blood supply from the sphenopalatine and caudal palatine arteries. The present study shows main differences between sheep and dogs VNO in which the structure of vomeronasal bone between the sheep and dog is completely different. The finding will illustrate fundamental differences and provide specific structural differences between the two species.

El órgano vomeronasal (OVN) se encuentra en la parte anteroinferior de la nariz y el órgano olfativo accesorio en los mamíferos es responsable del sentido del olfato. Este estudio tuvo como objetivo comparar la estructura macro y microanatómica del OVN entre ovejas y perros. En el estudio utilizamos diez ovejas adultas y diez perros adultos de diferentes sexos con edades de 1 a 2 años. Las cabezas de ambos animales se conservaron en formol al 10 % durante una semana. Este estudio mostró que en ambos animales, el OVN ocupa la misma posición en la cavidad del hueso vómer y la misma relación en la parte craneal de la cavidad nasal. Según su forma el OVN se divide en tres partes: rostral, central y caudal. Los resultados mostraron que el OVN en las ovejas tiene forma de (U) y está abierto dorsolateralmente. Presenta una cavidad pequeña y estrecha. Además, tiene una longitud de 6 cm y tiene diferentes diámetros en su recorrido. En comparación, el órgano vomeronasal en los perros está muy desarrollado y tiene forma de (J). Presenta una cavidad grande y larga y termina en el cuarto molar. Su longitud es de unos 10 cm y tiene un diámetro distinto en su recorrido. El OVN recibe el suministro de sangre de las arterias esfenopalatina y palatina caudal. El presente estudio muestra las principales diferencias entre el OVN de ovejas y perros en el que la estructura del hueso vomeronasal entre estos dos animales es completamente diferente. Además, los hallazgos ilustran diferencias fundamentales y determinan diferencias estructurales específicas entre las dos especies.

Comparison of the effectiveness of different high-flow devices in neonatal care

Abstract Objective: To evaluate the success rate of high-flow nasal cannula (HFNC) therapy using an adapted obsolete mechanical ventilator (MV), Optiflow™ and Vapotherm™ in newborns (NBs). Method: This was a retrospective observational study conducted in the neonatal intensive care unit (NICU). The sample comprised NBs who underwent HFNC therapy due to ventilatory dysfunction, for weaning from non-invasive ventilation (NIV), or post-extubation. The three groups, stratified according to gestational age (GA) and birth weight, and corrected GA and weight at the beginning of HFNC use, were as follows: Optiflow ™, Vapotherm ™, and obsolete Mechanical Ventilator (MV) adapted for high flow therapy. Subsequently, the NBs were divided into a success group (SG) and a failure group (FG). HFNC success was defined as a therapy duration exceeding 72 h. Results: A total of 209 NBs were evaluated, with 31.1 % using HFNC due to ventilatory dysfunction, 2.4 % after extubation, and 66.5 % after NIV weaning. HFNC success rate was observed in 90.9 % of the NBs, with no difference between equipment types (Vapotherm ™, Optiflow ™, and adapted VM). Conclusion: Different types of HFNC equipment are equally effective when used in neonatology for respiratory dysfunction, as a method of weaning from NIV and post-extubation. Adapted obsolete MV can be an alternative for HFCN therapy in resource-constrained settings.

Tumor nasal de músculo liso de comportamiento maligno incierto: informe de un caso / Nasal smooth muscle tumor of uncertain malignant potential: A case report

Los tumores de músculo liso que no pueden ser clasificados según su histología como leiomiomas o leiomiosarcomas se denominan tumores de músculo liso de comportamiento maligno incierto. La localización nasal de estos tumores es muy infrecuente y la extensión adecuada de la cirugía para tratar estas neoplasias no está bien definida. Se describe el caso clínico de una adolescente de 16 años, que consultó por padecer un tumor de aspecto vascular en la cavidad nasal derecha y que fue tratada con éxito mediante cirugía intranasal. El diagnóstico histológico fue tumor de músculo liso de comportamiento maligno incierto. Por la rareza de estas neoplasias, su infrecuente localización nasal y la falta de evidencia que soporte cuál debe ser la extensión de la cirugía, es relevante la descripción y discusión del caso clínico.

Smooth muscle tumors that cannot be histologically classified as leiomyomas or leiomyosarcomas are defined as smooth muscle tumors of uncertain malignant potential. The location of these tumors in the nose is very rare, and the appropriate surgical extent to manage these neoplasms has not been adequately defined. Here we describe the case of a 16-year-old female adolescent who consulted due to a vascular-like tumor in the right nasal cavity who was successfully treated with intranasal surgery. The histological diagnosis was smooth muscle tumor of uncertain malignant potential. Given that these neoplasms are rare, the uncommon location in the nose, and the lack of evidence indicating the extent of surgery, it is relevant to describe and discuss this clinical case.

Role of histopathological and microbiological investigations for a definitive diagnosis of benign sinonasal masses: a tertiary care institute study

Background: This research aimed to study the clinical presentation of various sino nasal masses (SNM), to study the importance of Histopathological and microbiological investigations in making diagnosis of SNM and to study the correlation between clinical, radiological, histopathological, and microbiological findings of SNM. Methods: In the present study 50 patients attending the ENT outpatient department with clinical evidence of nasal mass were selected based on inclusion and exclusion criteria. Patients were examined clinically and radiologically followed by surgical intervention. Histopathological and microbiological examination was done to make a definitive diagnosis. Results: Majority of cases were from 21-40 years age group (66%) with male preponderance. Nasal obstruction was most common symptom 45 (90%) followed by nasal discharge 43(86%). On histopathology highest incidence was of inflammatory polyps 22 (44%) followed by allergic polyps 14(28%) and non-invasive fungal sinusitis (NIFS) 11 (22%) respectively. Microscopically in KOH, fungal elements, yeast and hyphae were seen in total 11 (22%) cases and with SDA, Aspergillus niger was seen in 7 (14%) cases, Candida albicans in 3 (6%) and both in 1 (2%) case. Correlation of provisional diagnosis with HPE was found to be highly significant. Conclusions: It was observed that histopathological and microbiological examination is irreplaceable as both are the 揋OLD STANDARD� for making a definitive diagnosis.

Rinosinusitis crónica en fibrosis quística: una actualización / Chronic rhinosinusitis in cystic fibrosis: an update

En las últimas décadas, el tratamiento agresivo, protocolizado y realizado en centros multidisciplinarios de fibrosis quística (FQ), ha mejorado notablemente la sobrevida media de los pacientes. Como consecuencia, síntomas más bien secundarios, como los derivados del compromiso de la vía aérea superior, entre ellos la rinosinusitis crónica (RSC), con o sin pólipos nasales (PN), han empezado a impactar en la calidad de vida y en el curso de la enfermedad. Esto hace del diagnóstico y tratamiento oportuno de esta complicación un objetivo importante en el manejo de la FQ. El propósito de esta revisión es proporcionar una actualización sobre los aspectos diagnósticos y las terapias disponibles para el manejo de la RSC en pacientes con FQ.

In recent decades, aggressive, protocolized treatment conducted in multidisciplinary cystic fibrosis (CF) centers has significantly improved the median survival of patients. Consequently, secondary symptoms, such as those arising from upper airway involvement, including chronic rhinosinusitis (CRS), with or without nasal polyps (NP), have begun to impact the quality of life and the course of the disease. This makes timely diagnosis and treatment of this complication an important goal in CF management. The purpose of this review is to provide an update on diagnostic aspects and available therapies for managing CRS in patients with CF.

Cánula Nasal de Alto Flujo Asimétrica: una Revisión Narrativa / Asymmetrical High Flow Nasal Cannula: a Narrative Review

Los sistemas de Cánula nasal de alto flujo (CNAF) han sido ampliamente utilizados en el campo clínico como soporte no invasivo en el manejo de la falla respiratoria aguda (sobre todo hipoxémica) y cuidados post extubación. Clínica y fisiológicamente, las cánulas nasales de alto flujo son capaces de entregar un flujo de oxigeno alto que, debido a que ese gas se encuentra optimamente humidificado y calefaccionado, permite una mejor tolerancia por parte del paciente al ser comparada con las cánulas de oxigeno tradicionales. Por otra parte, este alto. Flujo es capaz de generar una presión positiva al final de la espiración (CPAP) en la vía área y favorecer tanto en barrido de dióxido de carbono (CO2) desde la vía aérea superior, lo que disminuye el trabajo respiratorio del paciente y mejora su confort.. Sin embargo; aún existe un alto porcentaje de pacientes que fracasan la terapia con CNAF y requiere soportes mas complejos como la ventilación mecánica, ya sea imvasiva o no. Estos resultados con la terapia CNAF pueden ser influidos por aspectos técnicos como, por ejemplo, la turbulencia que pueden generar estos sistemas a nivel de la región nasal. Por esta razón se han desarrollado nuevas tecnologías en el diseño y uso de interfaces para suministrar este alto flujo. Una de estas innovaciones es el uso de cánulas asimétricas, las que potencian los beneficios fisiológicos que entrega una cánula de alto flujo convencional. La presente revisión pretende exponer las principales diferencias que presenta el sistema de alto flujo convencional versus la nueva interface asimétrica.

High-flow nasal cannula (HFNC) systems have been widely used in the clinical field as non-invasive support in the management of acute respiratory failure (especially hypoxemic) and post-extubation care. Clinically and physiologically, high flow nasal cannulas are capable of delivering a high flow of oxygen which, because this gas is optimally humidified and heated, allows better tolerance by the patient when compared to traditional oxygen cannulas. . On the other hand, this high. Flow is capable of generating positive pressure at the end of expiration (CPAP) in the airway and favoring the sweep of carbon dioxide (CO2) from the upper airway, which reduces the patient's respiratory work and improves their comfort. .. However; There is still a high percentage of patients who fail therapy with HFNC and require more complex supports such as mechanical ventilation, whether invasive or not. These results with HFNC therapy can be influenced by technical aspects such as, for example, the turbulence that these systems can generate in the nasal region. For this reason, new technologies have been developed in the design and use of interfaces to provide this high flow. One of these innovations is the use of asymmetric cannulas, which enhance the physiological benefits provided by a conventional high-flow cannula. The present review aims to expose the main differences that the conventional high flow system presents versus the new asymmetric interface.

Quiste nasoalveolar unilateral derecho en adulto joven de 30 años / Right unilateral nasoalveolar cyst in a 30-year-old young adult

Introducción: El quiste nasolaveolar, conocido también como nasolabial o de Klestadt, se considera un raro quiste del desarrollo, epitelial y no odontogénico. Aparece en la región del ala nasal, produce asimetría facial, afecta la estética y puede conducir a alteraciones psicológicas. Objetivo: Presentar un caso clínico de quiste nasoalveolar unilateral derecho. Caso clínico: Paciente masculino de 30 años de edad, de color de piel negra, procedencia rural y con antecedentes de salud. Acudió a consulta por presentar aumento de volumen en ala nasal derecha, que producía obstrucción nasal y dificultades al respirar. El examen físico y complementarios imagenológicos revelaron diagnóstico presuntivo de quiste nasoalveolar unilateral derecho. Se procedió a la exéresis quirúrgica de la lesión bajo anestesia local sin complicaciones, el examen histopatológico confirmó el presunto diagnóstico. Conclusiones: El quiste nasoalveolar es una entidad clínica poco frecuente en Cuba y el mundo, su tratamiento es quirúrgico y es baja su recurrencia(AU)

Introduction: The nasolaveolar cyst, also known as nasolabial or Klestadt, is considered a rare developmental, epithelial and non-odontogenic cyst. It appears in the region of the nasal wing, produces facial asymmetry, affects aesthetics and can lead to psychological disorders. Objective: To present a clinical case of a right unilateral nasoalveolar cyst. Clinical case: A 30-year-old male patient, black, rural origin and with a history of health. He came to the consultation due to presenting an increase in volume in the right nasal wing, which caused nasal obstruction and difficulties in breathing. The physical and complementary imaging examinations revealed a presumptive diagnosis of a right unilateral nasoalveolar cyst. The lesion was surgically removed under local anesthesia without complications and histopathological examination confirmed the presumed diagnosis. Conclusions: The nasoalveolar cyst is a rare clinical entity in Cuba and the world, its treatment is surgical and its recurrence is low(AU)

Utilización de soportes respiratorios no invasivos post extubación en pacientes adultos críticos: revisión narrativa SRNI post extubación en adultos críticos / Use of Non-Invasive Respiratory Support in Critically Ill Patients Post-Extubation: a Narrative Review NIRS Post-Extubation in Critically Ill Adults

La tasa de reintubación orotraqueal luego de la extubación se registra entre un 10 a 20%. La aplicación de soportes respiratorios no-invasivos (SRNI) posterior a la extuba-ción como cánula nasal de alto-flujo, ventilación no invasiva (dos niveles de presión) y presión positiva continua en la vía aérea demostraron ser seguras y efectivas post ex-tubación. El período pre-destete representa un momento crucial en el manejo de los pa-cientes críticos ya que el fracaso de la extubación, definido como la necesidad de reintu-bación dentro de los 2 a 7 días, demostró peores resultados al aumentar la mortalidad entre un 25-50%. Esta situación conlleva al requerimiento de ventilación mecánica prolongada, neumonía asociada a la ventilación mecánica y estancias prolongadas de internación. Por lo tanto, es esencial identificar a los pacientes que se beneficiarán utilizando SRNI post extubación.

The rate of re-intubation after extubation is recorded at 10-20%. The use of non-invasive respiratory support (NIRS) post-extubation such as high-flow nasal cannula, non-invasive ventilation (bilevel pressure) and continuous positive airway pressure (CPAP) have been shown to be safe and effective post-extubation. The pre-weaning period represents a crucial time in the management of critically ill patients, as extubation failure, defined as the need for reintubation within 2-7 days, showed worse outcomes with mortality increasing by 25-50%. This situation leads to the requirement for prolonged mechanical ventilation, ventilator-associated pneumonia and long lengths of hospital stay. Therefore, it is essential to identify patients who will benefit from NIRS post extubation.

Rinoplastia secundaria: infección nasal en el postoperatorio / Secondary rhinoplasty: postoperative nasal infection

La rinoplastia es una de las intervenciones más comunes en cirugía plástica. Se opera aquí una rinoplastia secundaria por vía abierta injertando los alares y la punta con cartílagos auriculares, mientras el tabique cartilaginoso fue usado para los spreader grafts. Se describe aquí una infección posoperatoria de su punta nasal. Al 9no día de su posoperatorio comienza con la punta nasal congestiva y levemente inflamada. Se medica con una crema con antibióticos, pero el día 14 aparece con la punta nasal muy inflamada y con colección. Cuando en el consultorio el cirujano la ve, como cualquier absceso, decide realizarle drenaje con un trocar 18G, 3 miniincisiones en la piel debajo de la punta nasal, de la que drena un líquido amarronado. Luego con el mismo trocar se realiza un lavado dentro de la cavidad con rifampicina solución. Se medica con trimetoprima-sulfametoxazol (Bactrimforte®) 2 comp/día. Al otro día se observa una notable mejoría. Se continuó con lavado diario durante 4 días con el mismo antibiótico evolucionando rápidamente bien. El Bactrim se lo continúa por 20 días. Al mes la punta nasal está muy bien, deshinchada con cicatrices apenas visibles. A los cuatro meses, la punta está muy blanda, las alas nasales y las narinas normales, la punta con buena proyección igual que el dorso con los spreader graft.

Rhinoplasty is one of the most common interventions in plastic surgery. A secondary open rhinoplasty was carried out grafting the allae and the tip of the nose with conchae cartilage, while the septum was used for spreader grafts. We are here describing this post operatory with a tip of the nose infection.In the control, at the 9th postoperative day, the nasal tip began to be congested and at the 14th post op day the patient showed a clear inflammatory collection. In the office, the surgeon decided to evacuate it with three punctureslike little incisions at the inferior part of the skin tip with a trocar 18G. Through them, drained brownish purulent secretion. With the same trocar, rifampicin solution was injected through these little incisions, like washing the subdermal area. It was medicated with trimethoprim-sulfamethoxazole (Bactrim forte®) 2 tablets/day. The following day, there was a clear improvement in the congestion and erythema of the nose. This procedure of washing was repeated for four days. There was a quick evolution of the inflammatory process and 20 more days, there was no sign of the infection. Four months later, the tip of the nose was soft and the result was considered optimal by the patient and doctors.

Anatomical and Ultrasonographic Analyses of the Levator Labii Superioris Alaeque Nasi Muscle at the Level of the Nasal Ala / Análisis Anatómico y Ecográfico del Músculo Elevador Nasolabial a Nivel del Ala Nasal

SUMMARY: We aimed to determine the width of the levator labii superioris alaeque nasi muscle (LLSAN) at the level of the nasal ala through cadaveric dissections and ultrasonography (US), to provide essential anatomical information for use during both invasive and noninvasive procedures in the nasal ala region. The LLSAN was investigated in the 40 hemifaces of 20 Korean cadavers, comprising 10 males and 10 females with a mean age of 73.6 years. The LLSAN width of the 40 specimens at the level of the midpoint of the nasal ala was 5.02±2.35 mm (mean±standard deviation), and ranged from 1.45 mm to 10.11 mm. The LLSAN widths were 5.96±2.36 mm and 3.93±1.89 mm in males and females, respectively, with ranges of 2.40-10.11 mm and 1.45-6.96 mm, respectively. The LLSAN widths on the left and right sides were 4.77±2.72 mm and 5.26±1.99 mm, respectively. The proportions of the LLSAN fibers inserting into the nasal ala and upper lip were similar in 13 specimens (32.5 %), while more fibers inserted into the nasal ala in 11 specimens (27.5 %) and more fibers inserted fibers of the LLSAN into the upper lip in 16 specimens (40 %). When clinicians need to target or avoid the LLSAN, the present width and range data can be helpful for ensuring the efficacy and safely of both invasive and noninvasive procedures. In addition, the possibility of asymmetry in the width of the LLSAN in the nasal ala region should be confirmed by US before performing such procedures.

Nuestro objetivo fue determinar el ancho del músculo elevador nasolabial (MENL) a nivel del ala nasal mediante disecciones cadavéricas y ecografía, para proporcionar información anatómica esencial, para su uso durante procedimientos invasivos y no invasivos, en la región del ala nasal. El MENL se estudió en 40 hemicaras de 20 cadáveres coreanos (10 hombres y 10 mujeres) con una edad media de 73,6 años. El ancho de MENL de las 40 muestras a nivel del punto medio del ala nasal fue de 5,02 ± 2,35 mm (media ± desviación estándar) y osciló entre 1,45 mm y 10,11 mm. Los anchos de MENL fueron 5,96 ± 2,36 mm y 3,93 ± 1,89 mm en hombres y mujeres, respectivamente, con rangos de 2,40 a 10,11 mm y 1,45 a 6,96 mm, respec- tivamente. Los anchos de MENL en los lados izquierdo y derecho fueron 4,77 ± 2,72 mm y 5,26 ± 1,99 mm, respectivamente. Las proporciones de fibras de MENL que se insertaban en el ala nasal y en el labio superior fueron similares en 13 muestras (32,5 %), mientras que se insertaron más fibras en el ala nasal en 11 muestras (27,5 %) y además, se insertaron fibras de MENL en el labio superior en 16 ejemplares (40 %). Cuando los médicos necesitan apuntar o evitar el MENL, los datos actuales de ancho y rango pueden ser útiles para garantizar la eficacia y seguridad de los procedimientos, tanto invasivos como no invasivos. Además, la ecografía puede ser utilizada para confirmar una posible asimetría en el ancho del MENL en la región del ala nasal antes de realizar los procedimientos.

Masa nasal como único compromiso extrapulmonar de infección por M. Tuberculosis / Nasal mass as the only extrapulmonary compromise of M. Tuberculosis infection / Massa nasal como único compromisso extrapulmonar da infecção por M. Tuberculose

La tuberculosis aún es un problema de salud pública mundial. La infección causada por Mycobacterium tuberculosis se manifiesta de forma principal a nivel pulmonar. Sin embargo, alrededor del 20 % de los casos se presentan en otras localizaciones anatómicas y solo el 2 % tiene afectación del tracto respiratorio superior. Se presenta el caso de una mujer de 75 años, reconsultante al servicio de otorrinolaringología por epistaxis, lesiones postillosas en cavidad nasal y hallazgo de masa nasal. Posterior a la resección quirúrgica de la lesión, se logró la comprobación microbiológica de infección por M. tuberculosis. Se realizan estudios para descartar compromiso pulmonar y de otras localizaciones. Posterior al inicio de tratamiento antituberculoso se logró resolución completa de la lesión y no recurrencia de los síntomas. Las formas extrapulmonares de la infección por M. tuberculosis y, en especial las que afectan la región de la cabeza y el cuello, requieren un alto índice de sospecha para su diagnóstico. Los métodos de diagnóstico como la prueba de PCR y los cultivos de tejidos permiten un óptimo inicio del manejo médico de acuerdo con la epidemiología local y las condiciones del paciente.

Tuberculosis is still a global public health burden. Infection caused by the bacillus Mycobacterium tuberculosis (M. Tuberculosis) manifests mainly in the lungs. However, around 20 % of cases occur in other anatomical locations and only 2 % have upper respiratory tract involvement. We present the case of a 75-year-old female patient, who returned to the otorhinolaryngology service due to epistaxis and postillomous lesions in the nasal cavity with a finding of a nasal mass. After surgical resection of the lesion, microbiological confirmation of M. tuberculosis infection is achieved. Studies are performed to rule-out lung involvement, as well as other locations. After the initiation of tuberculosis treatment, complete resolution of the lesion and no recurrence of symptoms is documented. Extrapulmonary forms of M. tuberculosis infection, and especially those involving the head and neck region, require a high index of suspicion for their diagnosis. Diagnostic methods such as PCR testing and tissue cultures allow optimal initiation of medical management according to local epidemiology and patient conditions.

A tuberculose ainda é um problema de saúde pública global. A infecção causada pelo Mycobacterium tuberculoses manifesta-se principalmente nos pulmões. Entretanto, cerca de 20% dos casos ocorrem em outras localizações anatômicas e apenas 2% apresentam comprometimento do trato respiratório superior. É apresentado o caso de uma mulher de 75 anos que retornou ao serviço de otorrinolaringologia por quadro de epistaxe, lesões com crostas em cavidade nasal e descoberta de massa nasal. Após ressecção cirúrgica da lesão, foi realizada verificação microbiológica de infecção por M. tuberculoses. Estudos são realizados para descartar envolvimento pulmonar e otras localizações. Após início do tratamento antituberculoso, houve resolução completa dalesão e não houve recidiva dos sintomas. As formas extrapulmonares da infecção por M. tuberculoses, especialmente aquelas que acometem a região de cabeça e pescoço, requerem alto índice de suspeita para diagnóstico. Métodos de diagnóstico, como testes de PCR e culturas de tecidos, permitem o início ideal do tratamento médico de acordó com a epidemiologia local e as condições do paciente.